Representatives of Brussels-based offices leading the work of Health Working Group.
ERRIN’s Health Working Group (WG) supports members with early intelligence and regular updates about EU-level health policy-related issues, regulations, EU programmes and their funding opportunities. Creating opportunities for interregional cooperation in the Health area is one of the WG’s main objectives. The WG is also a vehicle for networking, profile raising and promoting good practices and projects among health stakeholders in the ERRIN regions.
The topic of widening gathers high attention in the discussions around the next European Framework Programme for R&I, raising questions with the potential to influence not only the Widening sub-
The Health Working Group meeting will update colleagues on the European Commission’s initiatives linked to staff and skills shortages and training and up-skilling of the health workforce, exploring
ERRIN has been closely involved in the design and implementation of the EU Missions since their inception. Missions remain one of the network's priorities and were one of the four main areas of focus
The Institute of History and Ethics of Medicine has organised a symposium on the ethical aspects of digital nursing solutions, which will take place in Germany this September.
Interested in the Farm to Fork strategy, sustainable food systems and the related Horizon 2020 Green Deal call? The Bioeconomy WG is hosting an information and project facilitation event on the Green Deal call area 6: Farm to Fork that will specifically emphasise the regional and local dimension and the multi-actor approach.
The European Patients' Forum, the European Rare Diseases Organisation and MEP Tiemo Wölken are co-organising a webinar in September.
The Scientific Panel for Health (SPH), established under Horizon 2020, is coming to its close as the framework period ends. During this online event, the panel will share its final recommendations for health research in Europe, developed through extensive stakeholder engagement over the last five years.
The representation of the State of Baden-Württemberg to the European Union is hosting a webinar on the topic of AI and personalised medicine.
The Health WG meeting will focus on the development process of the mission, which will be presented by Tomi Makela, Research Director at the Helsinki Institute of Life Science HiLIFE who takes part of the Mission Board on cancer.
The ERRIN Year in review 2022 is out! Read the report to see the numerous activities ERRIN and its members have been involved in throughout the year.
Please find attached ERRIN and the network of European Regional and Local Health Authorities (EUREGHA)'s joint statement on the Horizon Europe Mission on Cancer.
Further to the Health WG meeting on the Cancer Mission, EUREGHA and ERRIN have decided to address the Cancer Mission Board with a statement to emphasise the role of regions in this mission.
The Eu Cancer Mission project ONCODIR is organising a survey to consolidate its research work on the primary prevention of colorectal cancer. The survey is intended for citizens, clinicians and policymakers, and will expire on 31 July. It is a multiple-choice questionary and will take between 5-10 minutes to complete.
ERRIN is pleased to launch a series of input papers on the 10th Framework Programme, with this paper focusing on EU Missions. ERRIN has been closely involved in the design and implementation of the EU Missions since their inception, making them a priority for the network. This input paper on the role of EU Missions in FP10 has been created with contributions from ERRIN members and their ecosystems.
The REINFORCING project has opened a call to support organisations and territories that actively contribute to the EU Missions by engaging relevant stakeholders, including citizens, in the R&I process and/or policies connected to one of the Missions. Successful proposals will receive up to 60,000 euros to implement a 12-month project. The deadline for submitting proposals is 26 September 2024.
ERRIN is pleased to share a two-pager for the incoming European decision-makers, aiming to present the network and our value to the new MEPs, raising a voice for the importance of place-based R&I in the changing landscape. We encourage all ERRIN members to share the document with their MEPs to introduce ERRIN and the value of place-based R&I.
On 19 June, the Commission announced the 151 regions identified as Regional Innovation Valleys following the call for EoI and calls for proposals in 2023. 75 successful regions come from ERRIN members. RIVs will aim to strengthen the regional innovation ecosystems, bridge the innovation gap and improve Europe's overall innovation performance. New calls for proposals under Horizon Europe are expected in 2025.
As the work towards the next EU Framework Programme for R&I (FP10) continues, ERRIN is pleased to share its two-page input for the attention of the Expert Group on the interim evaluation of Horizon Europe. The document is a concise compilation of the reflections on FP10 done at ERRIN so far, highlighting topics of key importance. Work on a series of broader input papers is underway.
BioTrack BV (Leeuwarden, The Netherlands), has developed a rapid detection with very high precision. It allows for direct determination of COVID-19 mRNA in human (capillary) blood, nasal (nasopharyngeal) and throat (oropharyngeal) samples as well as stool samples.
Coventry University launched a suite of fully funded studentship opportunities that support the Global Challenges (GCRF) and UN Sustainable Development Goals.
Flanders Care is powering a new platform to generate proposals and eventually solutions during the COVID-19 outbreak.
The European Commission has launched a robotics and AI initiative in the frame of the common European response to the COVID-19 outbreak.
The Council adopted legislative act to rapidly react to the surrounding pandemic amending the rules of the structural and investment funds. Mechanisms will enter into force on 1 April.
ERRIN is joining organisers Ticbiomed in gathering technologies already available in the market that can help manage the healthcare crisis caused by the new coronavirus.